Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
22.64 EUR | -2.25% | -2.33% | +2.07% |
Apr. 25 | Transcript : Azelis Group NV, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024 | |
Apr. 18 | EQT Weighs Options for Belgian Chemical Distributor Azelis | MT |
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The firm trades with high earnings multiples: 21.32 times its 2024 earnings per share.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Industrial Goods Wholesale
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.07% | 5.9B | B | ||
+61.26% | 94.2B | A- | ||
+42.66% | 72.64B | B- | ||
+23.65% | 65.21B | B+ | ||
+7.21% | 41.71B | C | ||
+27.78% | 30.18B | B | ||
+17.81% | 22.53B | B | ||
+15.91% | 17.71B | B+ | ||
-4.14% | 12.93B | C+ | ||
-25.80% | 5.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AZE Stock
- Ratings Azelis Group NV